Intrasense and Guerbet Launch Liver Lesion Detection AI

Intrasense SA (FR:ALINS) has released an update.

Guerbet, a leader in medical imaging, and Intrasense, a medical imaging software company, have announced the CE marking of DUOnco™ Liver, an AI algorithm for detecting liver lesions. The technology aims to address challenges in liver cancer detection and monitoring by offering increased precision and significant time savings for patient care. Intrasense will integrate DUOnco™ Liver into their Liflow® 2.0 solution, enhancing diagnostic capabilities for healthcare professionals.

For further insights into FR:ALINS stock, check out TipRanks’ Stock Analysis page.